Clinical Trial Update: PROState Pathway Embedded Comparative Trial

View source ↗

Summary

The PROState Pathway Embedded Comparative Trial conducted by Imperial College London has completed and posted results on 2025-06-18.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-metastatic Prostate Cancer
• Prostate Adenocarcinoma
• Prostate Cancer
• Prostate Carcinoma in the Soft Tissue

Snippet

Sponsor: Imperial College London | Conditions: Prostate Cancer, Non-metastatic Prostate Cancer | Status: COMPLETED | Results posted: 2025-06-18